Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Teva
Daiichi Sankyo
Accenture
UBS
QuintilesIMS
Healthtrust
Colorcon
Cipla

Generated: August 24, 2017

DrugPatentWatch Database Preview

DEMEROL Drug Profile

« Back to Dashboard

Which patents cover Demerol, and when can generic versions of Demerol launch?

Demerol is a drug marketed by Us Pharm Holdings and Hospira and is included in two NDAs.

The generic ingredient in DEMEROL is meperidine hydrochloride. There are six drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the meperidine hydrochloride profile page.

Summary for Tradename: DEMEROL

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list5
Bulk Api Vendors: see list11
Clinical Trials: see list10
Patent Applications: see list1,793
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DEMEROL at DailyMed

Pharmacology for Tradename: DEMEROL

Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Us Pharm Holdings
DEMEROL
meperidine hydrochloride
INJECTABLE;INJECTION005010-007Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Us Pharm Holdings
DEMEROL
meperidine hydrochloride
TABLET;ORAL005010-004Approved Prior to Jan 1, 1982AARXYesYes► Subscribe► Subscribe► Subscribe
Us Pharm Holdings
DEMEROL
meperidine hydrochloride
INJECTABLE;INJECTION005010-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira
DEMEROL
meperidine hydrochloride
INJECTABLE;INJECTION021171-001Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
Us Pharm Holdings
DEMEROL
meperidine hydrochloride
INJECTABLE;INJECTION005010-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Us Pharm Holdings
DEMEROL
meperidine hydrochloride
INJECTABLE;INJECTION005010-009Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Us Pharm Holdings
DEMEROL
meperidine hydrochloride
TABLET;ORAL005010-001Approved Prior to Jan 1, 1982AARXYesYes► Subscribe► Subscribe► Subscribe
Us Pharm Holdings
DEMEROL
meperidine hydrochloride
SYRUP;ORAL005010-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira
DEMEROL
meperidine hydrochloride
INJECTABLE;INJECTION021171-003Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
Hospira
DEMEROL
meperidine hydrochloride
INJECTABLE;INJECTION021171-004Approved Prior to Jan 1, 1982APRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Citi
Teva
Cipla
Boehringer Ingelheim
Medtronic
US Army
Express Scripts
Healthtrust
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot